Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders
Arbutus Biopharma and its licensee Genevant have initiated multiple international lawsuits against Pfizer and BioNTech to enforce patents protecting their lipid nanoparticle technology used in mRNA COVID-19 vaccines. The company also received approximately $178 million from a settlement with Moderna over patent infringement, including reimbursement…